Probiotic supplements and bone health in postmenopausal women: a meta-analysis of randomised controlled trials.

BMJ open. 2021;11(3):e041393
Full text from:

Plain language summary

Osteoporosis is a disease where bone density is decreased and is often seen in postmenopausal women. Current prescribed treatments are costly and can often have serious side effects and as a result natural treatments are often requested. Probiotics have been shown in previous studies to be of benefit to bones, however no large review of all the available studies has been performed. This systematic review and meta-analysis of current randomised control trials (RCT’s) aimed to summarise the effect of probiotics on bone density in postmenopausal women. The results showed that only five RCT’s were available on the effect of probiotics on bone density of which there were 497 postmenopausal women. Bone density at the base of the spine was increased in women taking probiotics, however there was no difference seen in bone density of the hip. Bone markers for bone degradation were decreased, however other markers associated with bone density changes were unaffected. It was concluded that probiotics may increase bone density at the base of the spine, however more high-quality studies are needed. This study could be used by healthcare professionals to understand how probiotics may be of benefit to postmenopausal women, however definitive recommendations based on this study may need to be made with caution.

Abstract

OBJECTIVE Osteoporosis is a common disease in postmenopausal women. Several studies have analysed the associations between dietary supplementation with probiotics and bone health in postmenopausal women, but the results are still controversial. We conducted this meta-analysis to assess the effects of probiotics supplement on bone mineral density (BMD) and bone turnover markers for postmenopausal women. DESIGN Systematic review and meta-analysis. METHODS We systematically searched PubMed, EMBASE and the Cochrane Library from their inception to November 2020 for randomised controlled trials (RCTs) assessing probiotic supplements and osteoporosis in postmenopausal women. Study-specific risk estimates were combined using random-effect models. RESULTS Five RCTs (n=497) were included. Probiotic supplements were associated with a significantly higher BMD in the lumbar spine (standardised mean difference, SMD=0.27, 95% CI 0.09 to 0.44) than in control. There was no difference between probiotic supplements and BMD in hips (SMD=0.22, 95% CI -0.07 to 0.52). Collagen type 1 cross-linked C-telopeptide levels in the treatment groups were significantly lower than those of the placebo group (SMD=-0.34, 95% CI -0.60 to -0.09). In subgroup meta-analysis, levels of bone-specific alkaline phosphatase, osteoprotegerin, osteocalcin and tumour necrosis factor did not differ between the probiotic and placebo groups. CONCLUSIONS We conclude cautiously that supplementation with probiotics could increase lumbar BMD. More RCTs are recommended to validate or update these results.

Lifestyle medicine

Fundamental Clinical Imbalances : Structural
Patient Centred Factors : Mediators/Osteoporosis
Environmental Inputs : Microorganisms
Personal Lifestyle Factors : Nutrition
Functional Laboratory Testing : Not applicable
Bioactive Substances : Probiotics

Methodological quality

Jadad score : Not applicable
Allocation concealment : Not applicable
Publication Type : Journal Article ; Meta-Analysis

Metadata

Nutrition Evidence keywords : Osteoporosis ; Post menopausal ; Bone mineral density ; Probiotics